Inflammatory Bowel Disease Update for Advanced Practice Clinicians and Allied Health Professionals

This program happened in the past, and no dates are currently scheduled.

Select this button to navigate the sections of this page

Conference ID

J6107

Overview

There is increased awareness that the optimal treatment of patients with inflammatory bowel disease (IBD) requires a multidisciplinary approach, involving not only many medical specialties, but also many levels of care – primary care physicians, physician assistants, pharmacists, nurse practitioners, nurses, stoma specialists and dieticians, as well as the active involvement of the patients themselves and their families. While specialized IBD conferences for physicians abound, conference intended specifically for other professionals are lacking.

Our goal is to provide the most up-to-date information in the clinical, multidisciplinary care of patients with IBD. This program is structured in a clinical case format so as to provide relevant and practical information. Our faculty is composed of expert specialists, both physicians and advance practice clinicians in all key areas of IBD care.

Audience

The conference is intended for:

  • Primary care physicians
  • Physician specialists
  • Physician assistants
  • Nurses: Nurse practitioners; registered nurses; GI nurses; endoscopy nurses; wound, ostomy and continence nurses
  • Pharmacists
  • Dietitians
  • Other interested health-care professionals

Objectives

The objective of this program is to describe or explain latest clinical, scientific and therapeutic options and issues in inflammatory bowel disease – Crohn’s disease (CD) and ulcerative colitis (UC) management.

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PSNA

4.75 contact hours awarded.

Penn State Health Milton S. Hershey Medical Center is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

ACPE

The ACPE logo, black vaguely Romanic text with "AC" stacked directly on top of "PE," surrounded by a black-box border.Penn State Health Milton S. Hershey Medical Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned the Universal Activity Number of 0322-0000-18-020-L01-P. It has been approved for 4.75 contact hours (0.475 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. The attendee list will be uploaded into CPE Monitor approximately one week after completion of the program. Statements of credit indicated in contact hours and CEUs will be available through CPE Monitor. Successful completion includes signing in at registration with personal NABP number and date of birth, attending the entire session for which credit is claimed, and completing the activity evaluation. Penn State Health Milton S. Hershey Medical Center complies with the Accreditation Standards
for Continuing Education.

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all our sponsored educational programs. Faculty members are expected to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation.

Agenda

Morning General Sessions

  • 7:30 a.m. | Check-In/Continental Breakfast
  • 8 a.m. | Opening Remarks
    Walter A. Koltun MD, FACS, FASCRS
  • 8:15 a.m. | Three IBD-Related Topics
    • Defining and Diagnosing IBD
      Anne Bobb, BSN, RN
      Define the differences between CD and UC
    • Medical Treatment of IBD
      Kofi Clarke, MD, FACP, FRCP (Lond.)
      Summarize or explain the decision making in the medical treatment of IBD
    • Surgical Treatment of IBD
      Evangelos Messaris, MD, PhD, FACS, FASCRS
      Describe the surgical treatment of IBD.

Case Study 1: Severe Ulcerative Colitis

  • 9 a.m. | Medical Management of Severe UC and CD
    Matthew Coates, MD, PhD

    • Review clinical characteristics; discuss current medical therapies and their limitations for managing severe UC and CD.
    • Express the importance of a multi-disciplinary approach to patients with severe IBD.
  • 9:20 a.m. | Endoscopy in IBD: Advances in Dysplasia Detection and Management
    Matthew T. Moyer, MD, MS

    • Explain the prevalence and natural history of dysplasia in the IBD patient and the threat it poses to your IBD patient.
    • Review best practices in the management of dysplasia in the IBD patient as per recent guidelines.
  • 9:40 a.m. | Timing of Surgical Management
    Walter A. Koltun, MD, FACS, FASCRS

    • Define surgical options in the management of colonic dysplasia.
  • 10 a.m. | Q-and-A
  • 10:15 a.m. | Break/Visit Exhibits

Case Study 2: Crohn’s Disease with Perforating Terminal Ileum Abscess

  • 10:45 a.m. | Medical Therapy in Severe CD
    Emmanuelle D. Williams, MD

    • Describe the therapies for treating CD.
    • Compare and contrast risks and benefits of therapies in severe CD.
  • 11:05 a.m. | The Role of Radiology in Severe Perforating CD Diagnosis and Management
    Nabeel E. Sarwani, MD, FRCR

    • Review imaging of perforating CD and the role of drain placement for abscess control.
  • 11:25 a.m. | Surgical Management of Severe Perforating CD
    Walter A. Koltun, MD, FACS, FASCRS

    • Describe criteria for stoma creation in the surgical management of perforating ileal CD.
  • 11:45 a.m. | Q-and-A
  • Noon | Lunch/Exhibits

Case Study 3: The Pediatric Patient with a Severe Disease that isn’t Responding to Conventional Therapy

  • 1 p.m. | Medical Treatment of Severe Pediatric CD
    Marc Schaefer, MD, MPH

    • Describe treatment strategies for complex pediatric CD.
  • 1:20 p.m. | Surgical Indications in the Management of Pediatric IBD
    Dorothy V. Rocourt, MD, FACS

    • Discuss the timing for surgical intervention in patients with IBD.
  • 1:40 p.m. | Considerations in Transitioning a Pediatric IBD Patient to Adult Gastroenterology
    Marc Schaefer, MD, MPH

    • Describe Penn State IBD Center’s pediatric-to-adult care transitioning program.
  • 2 p.m. | Q-and-A
  • 2:15 p.m. | Break/Visit Exhibits

Case Study 4: Beyond Conventional Therapy

  • 2:30 p.m. | Health-Care Maintenance in IBD
    Nana E. Bernasko, CRNP, DNP, WHNP-BC

    • Discuss the current health-care maintenance guidelines in the adult IBD patient.
  • 2:50 p.m. | Complementary and Alternative Medicines in IBD
    Kofi Clarke, MD, FACP, FRCP (Lond.)

    • Explore the data surrounding complementary and alternative therapies for the management of IBD.
  • 3:10 p.m. | Nutrition Considerations in IBD
    Heather Tressler, MEd, RD, LDN, MCHES

    • Describe the importance of nutrition as well as popular diet options for IBD.
    • List strategies for controlling symptoms and flares.
  • 3:30 p.m. | Q-and-A
  • 3:45 p.m. | Adjournment

Faculty

Penn State Health Milton S. Hershey Medical Center:

Nana E. Bernasko, CRNP, DNP, WHNP-BC
IBD Nurse Practitioner
Gastroenterology and Hepatology

Anne Bobb, BSN, RN
Clinical Program Coordinator
Penn State College of Medicine
Penn State IBD Center

Kofi Clarke, MD, FACP, FRCP (Lond.)
Professor of Medicine
Chief, Gastroenterology and Hepatology
Penn State College of Medicine

Matthew Coates, MD, PhD
Assistant Professor of Medicine
Gastroenterology and Hepatology
Penn State College of Medicine

Walter A. Koltun, MD, FACS, FASCRS
Professor of Surgery
Director, Penn State IBD Center
Chief, Colon and Rectal Surgery
Peter and Marshia Carlino Chair in IBD
Penn State College of Medicine

Evangelos Messaris, MD, PhD, FACS, FASCRS
Associate Professor in Surgery
Colon and Rectal Residency Program Director
Colon and Rectal Surgery
Penn State College of Medicine

Matthew T. Moyer, MD, MS
Associate Professor of Medicine
Gastroenterology and Hepatology
Penn State College of Medicine
Penn State Cancer Institute

Dorothy V. Rocourt, MD, FACS
Associate Professor of Surgery and Pediatrics
Penn State College of Medicine
Penn State Children’s Hospital

Nabeel E. Sarwani, MD, FRCR
Associate Professor of Radiology
Penn State College of Medicine

Marc Schaefer, MD, MPH
Assistant Professor of Pediatrics
Associate Director, Pediatric IBD
Penn State College of Medicine
Penn State Children’s Hospital
Penn State IBD Center

Heather Tressler, MEd, RD, LDN, MCHES
Staff Nutritionist, Adult Gastroenterology
Penn State IBD Center

Emmanuelle D. Williams, MD
Assistant Professor of Medicine
Associate Director, Penn State IBD Center
Penn State College of Medicine

Fee

Fee is $95 per person and includes Break refreshments, cost of instruction, lunch and online handout materials.

Registrations received after Nov. 8, 2018, will incur a $25 late fee.

Cancellation

Cancellations received after Oct. 31, 2018, will incur a $25 processing fee.

No refunds will be given after Nov. 5, 2018.

The University may cancel or postpone any course or activity. If a program is canceled or postponed, the University will refund registration fees but is not responsible for any related costs, charges, or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Sponsor

This program is a continuing education service of Penn State College of Medicine.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. J6107

Jump to ...